Summary

Global Bispecific Antibodies For Cancer Market 2024-2028
The bispecific antibodies for cancer market is forecasted to grow by USD 314.3 mn during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the bispecific antibodies for cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer, advantages of bispecific antibodies over monoclonal antibodies, and strong pipeline.
Technavio's bispecific antibodies for cancer market is segmented as below:
By Type
• CD19 or CD3
• CD30 or CD16A
By Distribution Channel
• Hospitals
• Retail pharmacies
• Online
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the emerging bispecific antibody generation platforms as one of the prime reasons driving the bispecific antibodies for cancer market growth during the next few years. Also, increase in strategic alliances. and strong r and d in China will lead to sizable demand in the market.
The report on the bispecific antibodies for cancer market covers the following areas:
• Bispecific antibodies for cancer market sizing
• Bispecific antibodies for cancer market forecast
• Bispecific antibodies for cancer market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bispecific antibodies for cancer market vendors that include ABL Bio Inc., AFFIMED N.V., Akeso Inc., Amgen Inc., Aptevo Therapeutics Inc., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., Eli Lilly and Co., EPIMAB BIOTHERAPEUTICS INC., F STAR THERAPEUTICS INC., F. Hoffmann La Roche Ltd., Glenmark Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Mereo BioPharma Group Plc, Merus N.V., Pfizer Inc., Regeneron Pharmaceuticals Inc., TG Therapeutics Inc., Vadilal Industries Ltd., and Y mAbs Therapeutics Inc.. Also, the bispecific antibodies for cancer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/bispecific-antibodies-for-cancer-market-industry-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Executive Summary - Chart on Market Overview
o Executive Summary - Data Table on Market Overview
o Executive Summary - Chart on Global Market Characteristics
o Executive Summary - Chart on Market by Geography
o Executive Summary - Chart on Market Segmentation by Type
o Executive Summary - Chart on Market Segmentation by Distribution Channel
o Executive Summary - Chart on Incremental Growth
o Executive Summary - Data Table on Incremental Growth
o Executive Summary - Chart on Company Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Parent Market
o Data Table on - Parent Market
o 2.2 Market characteristics
o Market characteristics analysis
o 2.3 Value chain analysis
o Value Chain Analysis
• 3 Market Sizing
o 3.1 Market definition
o Offerings of companies included in the market definition
o 3.2 Market segment analysis
o Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Chart on Global - Market size and forecast 2023-2028 ($ million)
o Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global Bispecific Antibodies For Cancer Market 2018 - 2022
o Historic Market Size - Data Table on Global Bispecific Antibodies For Cancer Market 2018 - 2022 ($ million)
o 4.2 Type segment analysis 2018 - 2022
o Historic Market Size - Type Segment 2018 - 2022 ($ million)
o 4.3 Distribution Channel segment analysis 2018 - 2022
o Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
o 4.4 Geography segment analysis 2018 - 2022
o Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country segment analysis 2018 - 2022
o Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Chart on Type - Market share 2023-2028 (%)
o Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Chart on Comparison by Type
o Data Table on Comparison by Type
o 6.3 CD19 or CD3 - Market size and forecast 2023-2028
o Chart on CD19 or CD3 - Market size and forecast 2023-2028 ($ million)
o Data Table on CD19 or CD3 - Market size and forecast 2023-2028 ($ million)
o Chart on CD19 or CD3 - Year-over-year growth 2023-2028 (%)
o Data Table on CD19 or CD3 - Year-over-year growth 2023-2028 (%)
o 6.4 CD30 or CD16A - Market size and forecast 2023-2028
o Chart on CD30 or CD16A - Market size and forecast 2023-2028 ($ million)
o Data Table on CD30 or CD16A - Market size and forecast 2023-2028 ($ million)
o Chart on CD30 or CD16A - Year-over-year growth 2023-2028 (%)
o Data Table on CD30 or CD16A - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Type
o Market opportunity by Type ($ million)
o Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Chart on Distribution Channel - Market share 2023-2028 (%)
o Data Table on Distribution Channel - Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Chart on Comparison by Distribution Channel
o Data Table on Comparison by Distribution Channel
o 7.3 Hospitals - Market size and forecast 2023-2028
o Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
o Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
o Chart on Hospitals - Year-over-year growth 2023-2028 (%)
o Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
o 7.4 Retail pharmacies - Market size and forecast 2023-2028
o Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
o Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
o Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o 7.5 Online - Market size and forecast 2023-2028
o Chart on Online - Market size and forecast 2023-2028 ($ million)
o Data Table on Online - Market size and forecast 2023-2028 ($ million)
o Chart on Online - Year-over-year growth 2023-2028 (%)
o Data Table on Online - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Distribution Channel
o Market opportunity by Distribution Channel ($ million)
o Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Chart on Market share by geography 2023-2028 (%)
o Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Chart on Geographic comparison
o Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Chart on North America - Market size and forecast 2023-2028 ($ million)
o Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Chart on North America - Year-over-year growth 2023-2028 (%)
o Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Chart on Europe - Year-over-year growth 2023-2028 (%)
o Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Chart on Asia - Year-over-year growth 2023-2028 (%)
o Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Chart on US - Market size and forecast 2023-2028 ($ million)
o Data Table on US - Market size and forecast 2023-2028 ($ million)
o Chart on US - Year-over-year growth 2023-2028 (%)
o Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Ireland - Market size and forecast 2023-2028
o Chart on Ireland - Market size and forecast 2023-2028 ($ million)
o Data Table on Ireland - Market size and forecast 2023-2028 ($ million)
o Chart on Ireland - Year-over-year growth 2023-2028 (%)
o Data Table on Ireland - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Chart on China - Market size and forecast 2023-2028 ($ million)
o Data Table on China - Market size and forecast 2023-2028 ($ million)
o Chart on China - Year-over-year growth 2023-2028 (%)
o Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 Hungary - Market size and forecast 2023-2028
o Chart on Hungary - Market size and forecast 2023-2028 ($ million)
o Data Table on Hungary - Market size and forecast 2023-2028 ($ million)
o Chart on Hungary - Year-over-year growth 2023-2028 (%)
o Data Table on Hungary - Year-over-year growth 2023-2028 (%)
o 9.11 India - Market size and forecast 2023-2028
o Chart on India - Market size and forecast 2023-2028 ($ million)
o Data Table on India - Market size and forecast 2023-2028 ($ million)
o Chart on India - Year-over-year growth 2023-2028 (%)
o Data Table on India - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Market opportunity by geography ($ million)
o Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Opportunity/Restraints
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Impact of drivers and challenges in 2023 and 2028
o 10.4 Market opportunities/restraints
• 11 Competitive Landscape
o 11.1 Overview
o 11.2 Competitive Landscape
o Overview on criticality of inputs and factors of differentiation
o 11.3 Landscape disruption
o Overview on factors of disruption
o 11.4 Industry risks
o Impact of key risks on business
• 12 Competitive Analysis
o 12.1 Companies profiled
o Companies covered
o 12.2 Market positioning of companies
o Matrix on companies position and classification
o 12.3 ABL Bio Inc.
o ABL Bio Inc. - Overview
o ABL Bio Inc. - Product / Service
o ABL Bio Inc. - Key offerings
o 12.4 AFFIMED N.V.
o AFFIMED N.V. - Overview
o AFFIMED N.V. - Product / Service
o AFFIMED N.V. - Key news
o AFFIMED N.V. - Key offerings
o 12.5 Akeso Inc.
o Akeso Inc. - Overview
o Akeso Inc. - Product / Service
o Akeso Inc. - Key offerings
o 12.6 Amgen Inc.
o Amgen Inc. - Overview
o Amgen Inc. - Product / Service
o Amgen Inc. - Key news
o Amgen Inc. - Key offerings
o 12.7 Aptevo Therapeutics Inc.
o Aptevo Therapeutics Inc. - Overview
o Aptevo Therapeutics Inc. - Product / Service
o Aptevo Therapeutics Inc. - Key offerings
o 12.8 Astellas Pharma Inc.
o Astellas Pharma Inc. - Overview
o Astellas Pharma Inc. - Product / Service
o Astellas Pharma Inc. - Key news
o Astellas Pharma Inc. - Key offerings
o 12.9 Chugai Pharmaceutical Co. Ltd.
o Chugai Pharmaceutical Co. Ltd. - Overview
o Chugai Pharmaceutical Co. Ltd. - Product / Service
o Chugai Pharmaceutical Co. Ltd. - Key news
o Chugai Pharmaceutical Co. Ltd. - Key offerings
o 12.10 Eli Lilly and Co.
o Eli Lilly and Co. - Overview
o Eli Lilly and Co. - Product / Service
o Eli Lilly and Co. - Key news
o Eli Lilly and Co. - Key offerings
o 12.11 EPIMAB BIOTHERAPEUTICS INC.
o EPIMAB BIOTHERAPEUTICS INC. - Overview
o EPIMAB BIOTHERAPEUTICS INC. - Product / Service
o EPIMAB BIOTHERAPEUTICS INC. - Key offerings
o 12.12 F STAR THERAPEUTICS INC.
o F STAR THERAPEUTICS INC. - Overview
o F STAR THERAPEUTICS INC. - Product / Service
o F STAR THERAPEUTICS INC. - Key offerings
o 12.13 F. Hoffmann La Roche Ltd.
o F. Hoffmann La Roche Ltd. - Overview
o F. Hoffmann La Roche Ltd. - Business segments
o F. Hoffmann La Roche Ltd. - Key news
o F. Hoffmann La Roche Ltd. - Key offerings
o F. Hoffmann La Roche Ltd. - Segment focus
o 12.14 Glenmark Pharmaceuticals Ltd.
o Glenmark Pharmaceuticals Ltd. - Overview
o Glenmark Pharmaceuticals Ltd. - Product / Service
o Glenmark Pharmaceuticals Ltd. - Key news
o Glenmark Pharmaceuticals Ltd. - Key offerings
o 12.15 Johnson and Johnson Services Inc.
o Johnson and Johnson Services Inc. - Overview
o Johnson and Johnson Services Inc. - Business segments
o Johnson and Johnson Services Inc. - Key news
o Johnson and Johnson Services Inc. - Key offerings
o Johnson and Johnson Services Inc. - Segment focus
o 12.16 Mereo BioPharma Group Plc
o Mereo BioPharma Group Plc - Overview
o Mereo BioPharma Group Plc - Product / Service
o Mereo BioPharma Group Plc - Key offerings
o 12.17 Merus N.V.
o Merus N.V. - Overview
o Merus N.V. - Product / Service
o Merus N.V. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Inclusions checklist
o Exclusions checklist
o 13.3 Currency conversion rates for US$
o Currency conversion rates for US$
o 13.4 Research methodology
o Research methodology
o 13.5 Data procurement
o Information sources
o 13.6 Data validation
o Data validation
o 13.7 Validation techniques employed for market sizing
o Validation techniques employed for market sizing
o 13.8 Data synthesis
o Data synthesis
o 360 degree market analysis
o 360 degree market analysis
o 13.10 List of abbreviations
o List of abbreviations